PT Phapros Tbk
Chrisma Aryani Albandjar is an accomplished professional with extensive experience in corporate governance, public policy, and communications. Currently serving as a Commissioner at DANA Indonesia since February 2018, as well as an Independent Commissioner at PT Phapros Tbk, Chrisma has previously held significant roles including Chief Communications Officer at DANA, Commissioner at PT Kimia Farma, Special Advisor to the Chief of Staff in the Executive Office of the President of Indonesia, and Market Access and Policy Director at Merck. With a solid educational background including an MBA from Prasetiya Mulya Business School and a Master's degree from San Francisco State University, Chrisma specializes in corporate communications, government relations, and financial technology, contributing to various sectors including pharmaceuticals and digital finance.
This person is not in any teams
This person is not in any offices
PT Phapros Tbk
PT Phapros, Tbk is a pharmaceutical company which is a subsidiary of PT Kimia Farma (Persero), which currently control shares up to 56,7% and the rest is held by the public, including employees. The company has produced more than 284 items of drugs, and most of them are the result of the company development (non-licensed) that are classified into ethical, generic, OTC, and Agromed. Beside to produce its own drugs, PT Phapros, Tbk is trusted by the other pharmaceutical companies to produce pharmaceutical product through Contract Manufacturing cooperation. The products in addition to national needs as well as to the needs of other countries through export cooperation established since 2013.